Boundless Bio, Inc.
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.37% | 2.75% | -10.02% | -27.06% | 7.81% |
| Total Depreciation and Amortization | 12.98% | -1.13% | 0.76% | 6.48% | 5.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.83% | 28.34% | 9.03% | 149.10% | 90.73% |
| Change in Net Operating Assets | -169.59% | 375.64% | 62.92% | -779.44% | -133.09% |
| Cash from Operations | -17.31% | 18.29% | -2.92% | -35.00% | 4.13% |
| Capital Expenditure | 3.52% | 67.89% | -1,712.05% | 69.03% | -77.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -89.88% | 133.91% | -466.01% | 13.31% | 312.53% |
| Cash from Investing | -91.76% | 132.45% | -475.98% | 14.70% | 304.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 157,527.12% | 51.28% | -54.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 99.45% | -139.37% | 10.15% | -105.25% |
| Cash from Financing | 969.23% | -100.01% | 9,910.28% | 33.24% | -209.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -253.96% | 42.30% | 332.85% | -47.59% | 113.47% |